James Alexander Carter is a leading authority in the field of psychedelic research, with a primary focus on MDMA (3,4-methylenedioxymethamphetamine) and its applications in therapeutic settings. With over 15 years of dedicated study and hands-on experience, Carter has become a trusted voice in the conversation surrounding psychedelic-assisted treatment for mental health disorders.

Holding advanced degrees in neuroscience and psychopharmacology, Carter has contributed to groundbreaking clinical studies examining the safety, efficacy, and transformative potential of MDMA in treating conditions such as PTSD, anxiety, and depression. His work bridges the gap between science and therapy, promoting a deeper understanding of how MDMA can be responsibly integrated into modern healing practices.

Carter is also a sought-after speaker, author, and educator. He has presented at major psychedelic conferences, published peer-reviewed articles, and works closely with organizations advocating for the decriminalization and medical regulation of MDMA-assisted therapy. Known for his evidence-based approach and ethical commitment, James Alexander Carter continues to play a pivotal role in shaping the future of psychedelic medicine.

Whether consulting with research institutions or training new clinicians, Carter brings integrity, innovation, and insight to the evolving world of MDMA science.